(Q33966645)

30 July 2017

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial (English)

1 reference

30 July 2017

0 references

1 reference

3

Sarah Parish

1 reference

30 July 2017

5

Richard Peto

1 reference

30 July 2017

Rory Collins

1

1 reference

30 July 2017

Jane Armitage

series ordinal

2

1 reference

30 July 2017

Peter Sleigh

series ordinal

4

1 reference

30 July 2017

Heart Protection Study Collaborative Group

series ordinal

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

30 July 2017

1 reference

30 July 2017

361

1 reference

30 July 2017

2005-2016

1 reference

30 July 2017

9374

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Lipid lowering in patients with diabetes mellitus: what coronary heart disease risk threshold should be used?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Variation in diabetes care among states: do patient characteristics matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Report of the Conference on Low Blood Cholesterol: Mortality Associations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. The ETDRS Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Quantitative measurement of HbA1c by an immunoturbidimetric assay compared to a standard HPLC method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Management of dyslipidemia in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913636-7

7 January 2021

10.1016/S0140-6736(03)13636-7

Identifiers

DOI

1 reference

30 July 2017

1 reference